Literature DB >> 9350661

Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients.

P K Christensen1, H P Hansen, H H Parving.   

Abstract

We investigated the effect of acute lowering of blood pressure (BP) upon glomerular filtration rate (GFR) in hypertensive non-insulin-dependent diabetes mellitus (NIDDM) patients, 14 with diabetic nephropathy and 12 with normoalbuminuria. The study was performed twice with the subjects receiving an intravenous injection of either clonidine (150 to 225 micrograms) or saline (0.154 mmol/liter). We assessed GFR, albuminuria, and BP. The two groups were well matched with respect to demographic data, baseline GFR and BP. Clonidine induced similar reductions in mean arterial blood pressure 19 (SE +/- 4) and 21 (SE +/- 3) mm Hg in patients with and without nephropathy, respectively. In the nephropathy group GFR diminished in average from 90 (SE +/- 6) to 81 (SE +/- 7) ml/min/1.73 m2 (P = 0.006), fractional clearance of albumin (x 10(-6)) declined from a geometric mean of 219 (antilog SE /divided by 1.3) to 186 (antilog SE /divided by 1.3) (P = 0.04), and four patients had a complete pressure-passive vasculature, defined as delta GFR% = delta MABP%. A significant correlation between relative reductions in MABP and GFR (r = 0.78, P < 0.001) was demonstrated in albuminuric patients. None of the normoalbuminuric patients had a complete pressure-passive vasculature and there were no significant differences in GFR between the two examinations, but five had abnormal autoregulation of GFR. Mean difference between changes in GFR (95% confidence interval) between the nephropathic and normoalbuminuric group was 5.5 (divided by 2.7 to 13.7) ml/min/1.73 m2 (P = 0.18). Our study suggests that hypertensive NIDDM patients, particularly patients with nephropathy, frequently suffer from impaired or abolished autoregulation of GFR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350661     DOI: 10.1038/ki.1997.463

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-04-11       Impact factor: 4.132

3.  Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease.

Authors:  Kambiz Kalantarinia; Mark D Okusa
Journal:  Drug Discov Today Dis Mech       Date:  2007

Review 4.  Potential risks of calcium channel blockers in chronic kidney disease.

Authors:  Karen A Griffin; Anil K Bidani
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

Review 5.  High serum creatinine nonlinearity: a renal vital sign?

Authors:  Carlos E Palant; Lakhmir S Chawla; Charles Faselis; Ping Li; Thomas L Pallone; Paul L Kimmel; Richard L Amdur
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

6.  Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

Authors:  Utpal Sen; Suresh C Tyagi
Journal:  PPAR Res       Date:  2010-06-29       Impact factor: 4.964

Review 7.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Renal diffusion-weighted imaging in diabetic nephropathy: correlation with clinical stages of disease.

Authors:  Pınar Cakmak; Ahmet Baki Yağcı; Belda Dursun; Duygu Herek; Semin Melahat Fenkçi
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

9.  Arterial hypertension in diabetes mellitus: from theory to clinical practice.

Authors:  C Sampanis; C Zamboulis
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

Review 10.  Hypertensive renal damage: insights from animal models and clinical relevance.

Authors:  Karen A Griffin; Anil K Bidani
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.